{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:31Z","timestamp":1787240551610,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.farma.2022.12.008","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:57:56Z","timestamp":1682078276000},"page":"T50-T52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Therapeutic drug monitoring of voriconazole in a rapid-metabolizer patient with invasive pulmonary aspergillosis"],"prefix":"10.1016","volume":"47","author":[{"given":"Jorge","family":"Esquivel Negr\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"T\u00e9var Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"L\u00f3pez Travieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Merino Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Santos Fagundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.farma.2022.12.008_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society, Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.farma.2022.12.008_bb0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.farma.2022.12.008_bb0015","author":"Blanco Dorado"},{"issue":"5","key":"10.1016\/j.farma.2022.12.008_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/FPC.0000000000000276","article-title":"PharmGKB summary: voriconazole pathway, pharmacokinetics","volume":"27","author":"Barbarino","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.farma.2022.12.008_bb0025","author":"Marin-Marin"},{"issue":"Suppl 7","key":"10.1016\/j.farma.2022.12.008_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imj.15587","volume":"51","author":"Chau","year":"2021","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.farma.2022.12.008_bb0035","first-page":"184","article-title":"Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review","volume":"45","author":"S\u00e1ez-Garrido","year":"2021","journal-title":"Farm Hosp"},{"issue":"1","key":"10.1016\/j.farma.2022.12.008_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.farma.2022.12.008_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/antibiotics10050487","article-title":"Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole","volume":"10","author":"Risum","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"12","key":"10.1016\/j.farma.2022.12.008_bb0050","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/pharmaceutics13122099","volume":"13","author":"Cojutti","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634322000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634322000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:18:11Z","timestamp":1761106691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634322000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1130634322000174"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2022.12.008","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Therapeutic drug monitoring of voriconazole in a rapid-metabolizer patient with invasive pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2022.11.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}